This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Massachusetts. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Shashi Kant: Innovator in Cancer Treatment
Introduction
Shashi Kant is a notable inventor based in Shrewsbury, MA (US). He has made significant contributions to the field of cancer research through his innovative work on microRNAs and their role in angiogenesis and tumor development. His research aims to provide new methods for treating cancer effectively.
Latest Patents
Shashi Kant holds a patent for "MLK-regulated microRNAs in angiogenesis and tumor development." This patent outlines methods for treating cancer and reducing angiogenesis in tissue by administering one or more of a miR-371 oligonucleotide, a miR-146 oligonucleotide, or an inhibitor of MLK2/3 activity. This innovative approach has the potential to advance cancer treatment significantly.
Career Highlights
Shashi Kant is affiliated with the University of Massachusetts, where he conducts his research. His work has garnered attention for its potential impact on cancer therapies. With a focus on microRNA regulation, he is at the forefront of developing new strategies to combat cancer.
Collaborations
Shashi Kant collaborates with esteemed colleagues, including Siobhan Craige and Roger J Davis. These partnerships enhance the research efforts and contribute to the advancement of knowledge in the field of cancer treatment.
Conclusion
Shashi Kant's innovative work in cancer research exemplifies the importance of microRNA regulation in developing new treatment methods. His contributions are paving the way for future advancements in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile